Informace o publikaci

Hyperglycemia potentiates the effect of ionic calcium in photoreceptor ellipsoid zone disruption in diabetic retinopathy

Autoři

ANKITA Ankita STEFANICKOVA Jana SAXENA Sandeep NIM Dwividendra K. AHMAD Kaleem MAHDI Abbas A. KAUR Apjit BHASKER Shashi K. VALASKOVA Jela KRUŽLIAK Peter

Rok publikování 2019
Druh Článek v odborném periodiku
Časopis / Zdroj INTERNATIONAL OPHTHALMOLOGY
Fakulta / Pracoviště MU

Lékařská fakulta

Citace
www http://dx.doi.org/10.1007/s10792-018-01063-8
Doi http://dx.doi.org/10.1007/s10792-018-01063-8
Klíčová slova Diabetic retinopathy; Glycated hemoglobin; Serum calcium; Spectral-domain optical coherence tomography; Ellipsoid zone
Popis PurposeTo study the association of serum ionic calcium and glycated hemoglobin (HbA1c) with retinal photoreceptor ellipsoid zone (EZ) disruption in diabetic retinopathy (DR). MethodsThis is a tertiary care center-based observational cross-sectional study. Sixty-three consecutive cases, divided into 21 cases each with no diabetic retinopathy, non-proliferative diabetic retinopathy and proliferative diabetic retinopathy were included. Twenty-one healthy controls were also included. Ellipsoid zone disruption was assessed using spectral-domain optical coherence tomography. Serum ionic calcium and HbA1c were measured using standard protocol. Patient data from cases were divided into two groups according to their HbA1c levels: group 1 (HbA1c<7, n=26) and group 2 (HbA1c>7, n=37). Data were analyzed statistically.ResultsMean ionic calcium levels in group 1 and group 2 were 1.1310.073 mmol/dL and 1.170 +/- 0.070 mmol/dL, respectively. In group 1, 11 out of 26 had EZ disruption (42.3%). Similarly, in group 2, 29 out of 37 had EZ disruption (78.4%). On logistic regression analysis, as compared to group 1, ellipsoid zone disruption was found to be positively associated with serum ionic calcium (p=0.01) in group 2 cases.Conclusionp id=ParIncreased levels of serum ionic calcium are associated with increased EZ disruption in patients with HbA1c>7 in DR.

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.

Další info